SMS Pharmaceuticals Limited — Results, 12-02-2025: Integrated Filing- Financial

SMS Pharmaceuticals Limited has announced a board meeting to discuss the financial results for the quarter and nine-months period ended December 31, 2024. Total revenue increased to ₹17,548.14 cr, up from ₹16,297.30 cr year-over-year. Net profit rose to ₹1,717.23 cr for the quarter, reflecting strong operational performance. The company's expansion into new production capacities and backward integration of key materials aims to enhance sustainability and growth. Investors may view this as a positive outlook given the solid financial performance and strategic initiatives, although ongoing market dynamics should be monitored for potential risks.